China: Patent

Subscribe

Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.

The Patent Term Compensation And Protection Scope In The Compensated Period For Drug Invention Patents

The drugs claimed in drug invention patents must be approved by the National Medical Products Administration ("NMPA") before entering into market. Due to the long review period for drugs, it is very likely that a patent...

AC

AFD China

药品发明专利期限补偿及其间的保护范围

药品发明专利涉及的药品需经国家药品监督管理局审批后才可上市；由于药品审查周期较长，很可能专利已授权但是上市审批尚未完成。为保障专

AC

AFD China

智慧医疗的专利适格性讨论

人工智能（AI）技术的蓬勃发展正在重塑医药健康领域的技术边界。从早期的机器学习到AI大模型，医疗正在向更精准、更智能、更便捷的方向演进

K

Kangxin

关于优先权的那些事儿

我们在专利申请过程中，尤其是向中国以外的国家或地区申请专利时，经常会出现以在先申请为优先权提交在后申请的情况，那这个优先权是什么

K

Kangxin

越南2025年修订版《知识产权法》

R

Rouse

阿联酋使领馆认证新格式须知

R

Rouse

Chang Tsi Monthly Strategic Insights - January 2026: Towards A More Disciplined IP Regime: Legislative, Judicial And AI-Driven Developments In China

CT

Chang Tsi & Partners

WIPOが「2026年世界知的財産報告書」を発表へ、「イノベーションの拡散」に焦点を当てる

K

Kangxin

China Enters New Era In Patent Protection For Plant-related Inventions

CP

CCPIT Patent & Trademark Law Office

Patent Disclosure And AI Training: Legal Challenges And Institutional Responses

R

Rouse

海外知识产权资讯（2026.01）期

AC

AFD China

最高人民法院知的財産権法廷が集中審理：ハイテク特許の有効性に関わる紛争に焦点

K

Kangxin

中国の昨年の特許登録が97.2万件　AI関連の有効件数が世界上位水準

K

Kangxin

关注！欧洲专利局2026年4月1日起官费上涨

K

Kangxin

Hangzhou "AI Hallucination" Case - Key Takeaways On Duty Of Care For Generative AI Providers Operating In China

China Technology

GW

Gowling WLG

规行矩步，进而有为——中国私募基金行业年度观察报告（2025）

China Commercial

FP

Fangda Partners

中国・EU商工会議所が知財協力を協議　外資企業の知財保護と協力強化を確認

K

Kangxin

英国毕业生签证最新要求和新规解析｜UK Graduate Visa Rules & Requirements (Video)

China Immigration

L

Latitude Law

金融法律监管年度报告（2026）：银行业篇

FP

Fangda Partners

태양광 산업의 지식재산권 보호 업무 강화에 관한 의견 발표

국가지식산권국은 지난 12월31일 태양광 산업의 지식재산권 보호 업무 강화에 관한 의견을 발표하였다.

K

Kangxin

如何答复功能性限定权利要求的支持问题

其中，"权利要求书应当以说明书为依据"（也称为权利要求书应得到说明书的支持）是指权利要求书中的每一项权利要求所要求保护的技术方案应ঈ

K

Kangxin

Analysis Of The Supreme People's Court's Interpretation Of Several Issues Concerning The Application Of Law In The Trial Of Cases Of Disputes Over Patent Infringement (III) (Draft For Public Comment)

On December 20, 2025, the Supreme People's Court released the Supreme People's Court's Interpretation of Several Issues Concerning the Application of Law in the Trial of Cases of Disputes over Patent Infringement...

FP

Fangda Partners

Chang Tsi Webinar: Patent Judicial Interpretation (III) & Digital Protection

Recently, Chang Tsi & Partners held an online webinar focused on the Supreme People's Court's Draft Interpretation (III) regarding patent infringement disputes...

CT

Chang Tsi & Partners

坚持以精准服务为导向，做行业高质量发展的践行者

CP

CCPIT Patent & Trademark Law Office

News & Cases From China: January 2026

R

Rouse

最高法院知財法廷、累計2万4602件を受理　懲罰的賠償は総額20億元超

K

Kangxin

China's Amended Anti-Unfair Competition Law: Key Updates And Implications For Overseas Companies

CP

CCPIT Patent & Trademark Law Office

대외무역 관련 지식재산권 보호 내용이 포함된 대외무역법 개정

K

Kangxin

Korea vs. China: A Comparative Look At Invention Patent Examination Procedures

CT

Chang Tsi & Partners

【最高法知財法廷裁判要旨】他人の秘密漏洩を理由に新規性喪失の例外の適用を主張する声明の提出期限及びその起算点

K

Kangxin

Beijing Supreme People's Court Upholds Novo Nordisk Semaglutide Patent In China Based On Post-Filing Data

EI

Eagle IP

Thin Disclosure But "Bulletproof" Protection: How A Salt Form Patent Was Upheld In China Despite Minimal Data

EI

Eagle IP

全国検察機関、昨年1〜11月の知財侵害犯罪で1万7000人を起訴

K

Kangxin

【最高法知財法廷裁判要旨】他人の秘密漏洩を理由に新規性喪失の例外の適用を主張する声明の提出期限及びその起算点

特許出願人または特許権者が、他人がその同意を得ずに発明創造の内容を漏洩したことを理由として、新規性喪失の例外の適用を主張す声明を

K

Kangxin

Beijing Supreme People's Court Upholds Novo Nordisk Semaglutide Patent In China Based On Post-Filing Data

On December 31, 2025, The Supreme People's Court upheld the Beijing IP Court's decision, meaning that the semaglutide patent remains valid and will expire on March 20, 2026.

EI

Eagle IP

Thin Disclosure But "Bulletproof" Protection: How A Salt Form Patent Was Upheld In China Despite Minimal Data

In China, innovative drug companies typically rely on their initial composition of matter patents to block out competitors.

EI

Eagle IP

全国検察機関、昨年1〜11月の知財侵害犯罪で1万7000人を起訴

1月19日、全国検察長会議が北京で開催され、2025年における検察活動の状況が報告された。会議では、検察機関が市場経済秩序の維持に積極的に取&

K

Kangxin

特許取得がわずか85日に短縮　江蘇省が広域調整システムを運用開始

K

Kangxin

Infringement Determination On Treating External Data Generated By Supporting Software As Product Technical Features

In a patent infringement case, the Supreme People's Court established that when a product manufacturer provides software and an operation manual as essential components to achieve the functions of the accused product.

AC

AFD China

Judicial Determination Of "Tolerance" Defense In Patent Infringement Litigation

In a judgment concerning a dispute over infringement of an invention patent, the Supreme People's Court held that the scope of protection of a patent claim shall be determined by the content of the claim.

AC

AFD China

Identification Of False Litigation And Judicial Measures For Its Punishment

During an appeal hearing of a patent ownership dispute, the Supreme People's Court identified a prior concluded copyright ownership and infringement case between two involved parties.

AC

AFD China

2024년 전국 특허집약산업 부가가치 데이터 발표

12월31일 중국국가지식산권국 및 국가통계국은 2024년 전국 특허집약산업 부가가치 데이터를 발표하였다

K

Kangxin

中国、デジタル経済中核産業の特許登録件数が50万件に　世界首位を維持

K

Kangxin

Protecting Your Invention In China — Now More Than Ever

E

ENS

云南省知识产权局、省司法厅联合印发《关于推进专利侵权纠纷行政裁决工作体系建设加强知识产权法治保障的实施意见》

K

Kangxin

重庆市委深改委召开会议审议通过《重庆市构建知识产权全链条运营机制实施方案》

K

Kangxin

China Unveils Regulation On Commercial Mediation To Improve Business Environment

China Litigation

AC

AFD China

China And Czech Republic Extend PPH Pilot Program

AC

AFD China

IP5 PPH Pilot Program Extended

AC

AFD China

China Reports Rise In Patents And Stronger IP Enforcement

AC

AFD China

Legal Support For IPs To Be Bolstered

AC

AFD China

《世界主要城市数字经济创新与知识产权发展指数报告2025》发布

K

Kangxin

我国首部AI知识产权团体标准发布

K

Kangxin

欧洲专利局与欧洲药品协会首次举办双边会议

European Union IP

K

Kangxin

2026年世界知识产权日主题公布

K

Kangxin

国家知识产权强国建设工作部际联席会议办公室发布《知识产权强国建设发展报告（2025年）》

K

Kangxin

江蘇省、渉外知的財産法務サービス連盟を発足　企業の国際展開を支える

K

Kangxin

See more

Latest Videos

See more

Sheppard Mullin China Monthly IP Seminar – Nov. 2021: Different Ways To Invalidate Patents (Video)

SM

Sheppard, Mullin, Richter & Hampton LLP

IP Snacks: Recent Amendments To The Chinese Patent Law (Video)

R

Rouse

Doing Business In China (Video)

IP

IPO Pang Xingpu

Channel Management In China (Video)

AP

AJ Park

Azure IP Advantage In China: Towards ‘Quiet Enjoyment' In The Global Cloud? (Video)

KI

Kemp IT Law

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More